You are here

Daxxify

Goldman Sachs says this biotech working on a Botox rival drug could rally nearly 30%

Goldman Sachs says this biotech working on a Botox rival drug could rally nearly 30%

CNBC

Revance Therapeutics

Flag link:

AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved

AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved

Endpoints

Revance Therapeutics

Flag link:

Longer-lasting Botox competitor nabs FDA approval — can it compete with AbbVie's $2B cash cow?

Longer-lasting Botox competitor nabs FDA approval — can it compete with AbbVie's $2B cash cow?

Endpoints

Revance Therapeutics

Flag link: